A Range of Contact Lenses and Care System Combinations

August 11, 2020 updated by: CooperVision, Inc.
The objective of this study is to compare the short-term clinical response to all combinations of two lens types: fanfilcon A and comfilcon A with two care systems: Hy-Care and Lite. The primary variables of interest are short-term biomicroscopy signs. Other variables of interest include subjective response and visual performance.

Study Overview

Detailed Description

Subjects were randomized to wear fanfilcon A soft contact lens in one eye and comfilcon A soft contact lens in the other eye with each lens having been soaked overnight in the Hy-Care contact lens solution and Lite contact lens solution.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Manchester, United Kingdom, M13 9PL
        • Eurolens Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. They are of legal age (18) and capacity to volunteer.
  2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  3. They are willing and able to follow the protocol.
  4. They agree not to participate in other clinical research for the duration of this study.
  5. They can be satisfactorily fitted with the study lens for a period of approximately 2 hours.
  6. They can attain at least 0.20 logMAR distance high contrast visual acuity in each eye with their habitual spectacles.
  7. They currently wear daily disposable soft contact lenses or have done so in the previous six months.
  8. They are willing to comply with the wear schedule (approximately 2 hours on two different days)
  9. They own a wearable pair of spectacles and agree to bring these to study visits.

Exclusion Criteria:

  1. They have an ocular disorder which would normally contra-indicate contact lens wear.
  2. They have a systemic disorder which would normally contra-indicate contact lens wear.
  3. They currently wear reusable soft contact lenses in both eyes.
  4. They are using any topical medication such as eye drops or ointment.
  5. They have had cataract surgery.
  6. They have had corneal refractive surgery.
  7. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  8. They are pregnant or breast-feeding.
  9. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
  10. They have Type 2 or greater corneal staining prior to lens application at Visit 1 or 2
  11. They have corneal staining covering greater than 20% in any corneal region at Visit 1a or 2a
  12. They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
  13. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Hy-Care Contact Lens Solution
Each subject will wear fanfilcon A soft contact lens in one eye and comfilcon A soft contact lens in the other eye with each lens having been soaked overnight in the Hy-Care contact lens solution.
Hy-Care Contact Lens Solution
fanfilcon A soft contact lens
comfilcon A soft contact lens
Active Comparator: Lite Contact Lens Solution
Each subject will wear fanfilcon A soft contact lens in one eye and comfilcon A soft contact lens in the other eye with each lens having been soaked overnight in the Lite contact lens solution.
fanfilcon A soft contact lens
comfilcon A soft contact lens
Lite Contact Lens Solution

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biomicroscopy - Conjuctival Hyperaemia
Time Frame: Baseline (before lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before lens insertion)
Biomicroscopy - Conjuctival Hyperaemia
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours
Biomicroscopy - Limbal Hyperaemia
Time Frame: Baseline (before contact lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before contact lens insertion)
Biomicroscopy - Limbal Hyperaemia
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours
Biomicroscopy - Corneal Vascularisation
Time Frame: Baseline (before lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before lens insertion)
Biomicroscopy - Corneal Vascularisation
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours
Biomicroscopy - Microcysts
Time Frame: Baseline (before lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before lens insertion)
Biomicroscopy - Microcysts
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours
Biomicroscopy - Oedema
Time Frame: Baseline (before lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before lens insertion)
Biomicroscopy - Oedema
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours
Biomicroscopy - Conjunctival Staining
Time Frame: Baseline (before lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before lens insertion)
Biomicroscopy - Conjunctival Staining
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours
Biomicroscopy - Papillary Conjunctivitis
Time Frame: Baseline (before lens insertion)
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
Baseline (before lens insertion)
Biomicroscopy - Papillary Conjunctivitis
Time Frame: 2 hours
Ocular physiology assessment of fanfilcon A and comfilcon A contact lenses with lens care products Lite and Hy-Care biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).
2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort
Time Frame: Baseline 5 minutes after lens insertion
Subjective ratings of comfort for each pair of lenses (scale: 0-100; 0=Cannot be tolerated,100=Cannot be felt).
Baseline 5 minutes after lens insertion
Comfort
Time Frame: 2 hours
Subjective ratings of comfort for each pair of lenses (scale: 0-100; 0=Cannot be tolerated,100=Cannot be felt).
2 hours
Dryness
Time Frame: 2 hours
Subjective ratings of dryness for each pair of lenses measured only at follow up (scale: 0-100; 0=Intolerable levels of dryness, 100=No sensation of dryness).
2 hours
Overall Score
Time Frame: Baseline 5 minutes after lens insertion
Subjective ratings of overall score for each pair of lenses (scale: 0-100; 0=Cannot use lenses, 100=Highly impressed with lenses overall).
Baseline 5 minutes after lens insertion
Overall Score
Time Frame: 2 hours
Subjective ratings of overall score for each pair of lenses (scale: 0-100; 0=Cannot use lenses, 100=Highly impressed with lenses overall).
2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Philip Morgan, PhD MCOptom FAAO FBCLA, Eurolens Research

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2018

Primary Completion (Actual)

October 23, 2018

Study Completion (Actual)

December 12, 2018

Study Registration Dates

First Submitted

August 13, 2018

First Submitted That Met QC Criteria

August 13, 2018

First Posted (Actual)

August 15, 2018

Study Record Updates

Last Update Posted (Actual)

August 24, 2020

Last Update Submitted That Met QC Criteria

August 11, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • C17-635 (EX-MKTG-95)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contact Lens Solutions

Clinical Trials on Hy-Care Contact Lens Solution

Subscribe